FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Reckitt Benckiser Cherry Cepacol Sore Throat Lozenges Recall

Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3

Reckitt Benckiser Inc · Parsippany, NJ

Risk level
Class III
Reported by FDA
May 8, 2013
Recall ID
D-310-2013
Check your lot numberHow we source this data

Summary

Reckitt Benckiser recalled Cherry Cepacol Sore Throat Lozenges starting Mar 18, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-310-2013 on May 8, 2013. Reason: Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine. Status: Terminated.

Why it was recalled

Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.

Product description

Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054

Lot numbers, UPCs & expiration codes

16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398 Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13,

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-310-2013
Classification
Class III
Status
Terminated
Recall initiated
Mar 18, 2013
FDA report date
May 8, 2013
Quantity
27,718 cases 16 count and 7,551 cases 576 count
Recall type
Voluntary: Firm initiated
Recalling firm
Reckitt Benckiser Inc

Original FDA data

Every field from FDA enforcement report D-310-2013, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
64652
Address
399 Interpace Parkway
Code information
16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398 Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13,
Postal code
07054
Report date
May 8, 2013
Product type
Drugs
Recall number
D-310-2013
Classification
Class III
Recalling firm
Reckitt Benckiser Inc
Product quantity
27,718 cases 16 count and 7,551 cases 576 count
Termination date
Aug 14, 2014
Reason for recall
Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054
Distribution pattern
Nationwide
Recall initiation date
Mar 18, 2013
Initial firm notification
Letter
Center classification date
May 1, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-310-2013, published May 8, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls